SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

Dr. Andrés Rodríguez - 22 May, 2026 0

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

Dr. Andrés Rodríguez - 22 May, 2026 0

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

Dr. Omar Tupayachi - 22 May, 2026 0

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

Noticias Institucionales

SOLACI Presented an Outstanding Scientific Session on Complex Coronary Lesions at EuroPCR 2026

solaci - 22 May, 2026 0

The Latin American Society of Interventional Cardiology (SOLACI) had a prominent participation at EuroPCR 2026 through an institutional scientific session held on May 21...

Relive SOLACI’s participation in the V International Congress of Clinical and Interventional Cardiology in the Dominican Republic

solaci - 21 May, 2026 0

The Latin American Society of Interventional Cardiology actively participated in the “V International Congress of Clinical and Interventional Cardiology”, organized by the Asociación Dominicana...

SOLACI to Participate in EuroPCR 2026 with a Scientific Session Focused on the Management of Complex Coronary Lesions

solaci - 20 May, 2026 0

The Latin American Society of Interventional Cardiology will have a prominent participation at EuroPCR 2026 through an institutional scientific session bringing together renowned international...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad

Tag: CTO

EuroPCR 2022 | The IMPROVED-CTO Trial

Transfemoral vs Transradial Approach in the Percutaneous Treatment of CTO

Lower Mortality with Rechanneling vs. Medical Therapy

Should Total Occlusion Influence on Revascularization Strategy?

Suboptimal Recanalization Results Worse than Procedural Failure

Subintimal Re-Entry in CTO Improves Outcomes

Subintimal vs. Intraplaque Coronary Rechanneling. Do Results Vary?

TCT 2019 | FORZA: OCT vs FFR to Define Intermediate Lesions:...

TCT 2019 | EURO-CTO: Results at 3 Years of CTO Recanalization...

Antianginal Medication Before and After Rechanneling